Non specific chronic low back pain. Low back pain
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with chronic non-specific low back pain between the ages of 18-50 years with minimum literacy in the cycle. Having chronic back pain more than 3 month. Tenderness and pain more than 3 score on visual analogue scale when palpating muscle tissue at the level of the fourth and fifth lumbar vertebrae. Patients who did not have a disc protrusion or were bulging, according to (Magnetic Resonance Imaging)MRI findings People whose primary trigger point is in the lumbar multifidus muscle Individuals with multifidus muscle weakness from moderate to severe fat infiltration based on MRI findings.
Exclusion criteria
Exclusion criteria: Subjects with specific low back pain Subjects with protrusion, extrusion or sequestration lumbar discopathy according to MRI findings Individuals with multifidus muscle weakness from normal to mild fat infiltration based on MRI findings. People with fear of dry needling People with fibromyalgia according to the criteria of the American School of Rheumatology (2017) whose symptoms are: Bilateral pain in at least 11 of the following 18 tender points: suboccipitalis muscles, lower cervical, trapezius, supraspinatus, second rib, lateral epicondyle, gluteal, greater trochanter and knee People with rheumatoid arthritis, rheumatic diseases, degenerative diseases, fractures, lumbar dislocations People with fever, severe weight loss, nocturnal pain, sudden anesthesia, urinary and fecal disorders People with lumbar, pelvic and lower extremities myopathy and and myelopathy People with progressive neurological disorders and a history of lower limb and spine surgery People with a history of injections into the trigger points of the multifidus muscle or dry needling during the previous 6 months and people with cancer, pain and lung disease, acquired immunodeficiency virus Athletes: Because they may differ from non-athletes in terms of muscle stiffness, muscle thickness and fascia, as well as the quality of exercise. People with substance abuse or corticosteroid medications as well as pregnant women People who have been undergoing regular physiotherapy or exercise for the past two weeks Take sedatives or alcohol one week before the assessment Individuals with psychosocial disorders who will be assessed using the Persian version of the DASS-21 Stress-Anxiety-Depression Questionnaire and obtain above-normal scores.(Normal Scores: up to 9 = Depression, up to 7) = Anxiety, up to 14 = stress) People with bleeding disorders and the use of anticoagulants
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: Before intervention, after five sessions treatments, three month follow-up. Method of measurement: Visual Analogue Scale.;Functional disability. Timepoint: Before intervention, after five sessions treatments, three month follow-up. Method of measurement: Oswestry disability index.;Thickness and percentage of thickness changes of multifidus muscle in rest and contraction. Timepoint: Before intervention, after five sessions treatments, three month follow-up. Method of measurement: Using ultrasonography.;Cross sectional area of multifidus muscle in rest and contraction. Timepoint: Before intervention, after five sessions treatments, three month follow-up. Method of measurement: Using ultrasonography.;Pressure pain threshold. Timepoint: Before intervention, after five sessions treatments, three month follow-up. Method of measurement: Pressure algometer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Iran University of Medical Sciences